Diabetes Mellitus and the Risk of Cholangiocarcinoma: an Updated Meta-analysis

Overview

Journal Prz Gastroenterol

Publisher Termedia

Specialty Gastroenterology

Date 2015 Nov 12

PMID 26557943

Citations 12

Authors

Junshan Li

Tianjie Han

Linlin Xu

Xiaotian Luan

Affiliations

Soon will be listed here.

Abstract

Introduction: A number of studies have shown that diabetes mellitus is implicated in susceptibility to several cancers. However, the relationship between diabetes and cholangiocarcinoma remain unclear.

Aim: To quantitatively assess the relationship between diabetes and incidence of cholangiocarcinoma in cohort and case-control studies.

Material And Methods: A literature search was performed for entries from 1996 to 2014 using the PubMed and EMBASE databases. Studies were included if they reported odds ratios (OR) and corresponding 95% CI of cholangiocarcinoma with respect to diabetes mellitus.

Results: Twenty studies met the inclusion criteria, which included fifteen case-control studies and five cohort studies from Asia (n = 11), the United States (n = 5), and Europe (n = 4). Compared with individuals without diabetes, the pooled OR of cholangiocarcinoma was 1.74 (95% CI: 1.62-1.87, p = 0.568 for heterogeneity) for patients with diabetes, ICC (summary RR, 1.93; 95% CI: 1.65-2.25; p = 0.037 for heterogeneity), and ECC (summary RR, 1.66; 95% CI: 1.39-1.98; p = 0.001 for heterogeneity). The funnel plot revealed no evidence for publication bias concerning diabetes and the risk of CC (including ICC and ECC).

Conclusions: The findings from this meta-analysis suggest that diabetes may increase the risk of cholangiocarcinoma. This relationship needs to be confirmed by further follow-up studies.

Citing Articles

Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights.

Di Stasi V, Contaldo A, Birtolo L, Shahini E Cancers (Basel). 2024; 16(19).

PMID: 39410050 PMC: 11476000. DOI: 10.3390/cancers16193432.

Widening Health Disparities: Increasing Cholangiocarcinoma Incidence in an Underserved Population.

Kumar D, Bansal V, Raza S, Thrift A, Malaty H, Sealock R Gastro Hep Adv. 2024; 1(2):180-185.

PMID: 39131132 PMC: 11308073. DOI: 10.1016/j.gastha.2021.12.003.

Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand.

Thinkhamrop K, Suwannatrai K, Kelly M, Suwannatrai A Sci Rep. 2024; 14(1):10510.

PMID: 38714779 PMC: 11076619. DOI: 10.1038/s41598-024-61282-1.

Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide.

Hormati A, Hajrezaei Z, Jazi K, Kolur Z, Rezvan S, Ahmadpour S Middle East J Dig Dis. 2023; 14(1):5-23.

PMID: 36619733 PMC: 9489325. DOI: 10.34172/mejdd.2022.251.

Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination.

Gromowski T, Lukacs-Kornek V, Cisowski J Cancer Cell Int. 2023; 23(1):3.

PMID: 36609378 PMC: 9824961. DOI: 10.1186/s12935-022-02843-0.

References

Noel M, Hezel A . New and emerging treatment options for biliary tract cancer. Onco Targets Ther. 2013; 6:1545-52. PMC: 3817087. DOI: 10.2147/OTT.S32545. View

El-Serag H, Engels E, Landgren O, Chiao E, Henderson L, Amaratunge H . Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2008; 49(1):116-23. PMC: 2719902. DOI: 10.1002/hep.22606. View

Festi D, Dormi A, Capodicasa S, Staniscia T, Attili A, Loria P . Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol. 2008; 14(34):5282-9. PMC: 2744058. DOI: 10.3748/wjg.14.5282. View

Jamal M, Yoon E, Vega K, Hashemzadeh M, Chang K . Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol. 2009; 15(42):5274-8. PMC: 2776853. DOI: 10.3748/wjg.15.5274. View

Grainge M, West J, Solaymani-Dodaran M, Aithal G, Card T . The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer. 2008; 100(1):178-80. PMC: 2634685. DOI: 10.1038/sj.bjc.6604765. View

Welzel T, Graubard B, El-Serag H, Shaib Y, Hsing A, Davila J . Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007; 5(10):1221-8. PMC: 2083573. DOI: 10.1016/j.cgh.2007.05.020. View

Adami H, Chow W, Nyren O, Berne C, Linet M, Ekbom A . Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996; 88(20):1472-7. DOI: 10.1093/jnci/88.20.1472. View

Khan S, Emadossadaty S, G Ladep N, Thomas H, Elliott P, Taylor-Robinson S . Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. J Hepatol. 2011; 56(4):848-54. DOI: 10.1016/j.jhep.2011.11.015. View

El-Serag H, Hampel H, Javadi F . The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4(3):369-80. DOI: 10.1016/j.cgh.2005.12.007. View

10.

Zhou Y, Yin Z, Yang J, Li B, Shao W, Xu F . Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol. 2008; 14(4):632-5. PMC: 2681159. DOI: 10.3748/wjg.14.632. View

11.

Seyama Y, Makuuchi M . Current surgical treatment for bile duct cancer. World J Gastroenterol. 2007; 13(10):1505-15. PMC: 4146891. DOI: 10.3748/wjg.v13.i10.1505. View

12.

Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T . Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004; 95(7):592-5. PMC: 11158843. DOI: 10.1111/j.1349-7006.2004.tb02492.x. View

13.

Shebl F, Andreotti G, Rashid A, Gao Y, Yu K, Shen M . Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer. 2010; 103(1):115-9. PMC: 2905288. DOI: 10.1038/sj.bjc.6605706. View

14.

Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M . Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005; 92(11):2076-83. PMC: 2361795. DOI: 10.1038/sj.bjc.6602619. View

15.

Liu Z, Zhou Y, Shi L, Yin Z . Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int. 2011; 10(6):626-31. DOI: 10.1016/s1499-3872(11)60106-9. View

16.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

17.

Patel T . Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(1):33-42. DOI: 10.1038/ncpgasthep0389. View

18.

Cai W, Sima H, Chen B, Yang G . Risk factors for hilar cholangiocarcinoma: a case-control study in China. World J Gastroenterol. 2011; 17(2):249-53. PMC: 3020381. DOI: 10.3748/wjg.v17.i2.249. View

19.

Biddinger S, Haas J, Yu B, Bezy O, Jing E, Zhang W . Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008; 14(7):778-82. PMC: 2753607. DOI: 10.1038/nm1785. View

20.

Lee T, Lee S, Jung S, Jeon S, Yun S, Oh H . Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol. 2008; 103(7):1716-20. DOI: 10.1111/j.1572-0241.2008.01796.x. View